De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

China Health Group Beheer

Beheer criteriumcontroles 4/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Ho Chung

Algemeen directeur

HK$1.2m

Totale compensatie

Percentage CEO-salaris	98.5%
Dienstverband CEO	6.8yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	6.6yrs
Gemiddelde ambtstermijn bestuur	9.1yrs

Recente managementupdates

Here's Why China Health Group Limited's (HKG:673) CEO Compensation Is The Least Of Shareholders' Concerns

Sep 05

Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation

Sep 11

Recent updates

Here's Why China Health Group Limited's (HKG:673) CEO Compensation Is The Least Of Shareholders' Concerns

Sep 05

Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation

Sep 11

We Think China Health Group (HKG:673) Has A Fair Chunk Of Debt

Dec 01

We Discuss Why China Health Group Limited's (HKG:673) CEO May Deserve A Higher Pay Packet

Sep 23

We Think Some Shareholders May Hesitate To Increase China Health Group Limited's (HKG:673) CEO Compensation

Sep 02

Did China Health Group Limited (HKG:673) Insiders Sell Shares?

Feb 16

Analyse CEO-vergoeding

Hoe is Ho Chung's beloning veranderd ten opzichte van China Health Group's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Mar 31 2024	HK$1m	HK$1m	-HK$40m
Dec 31 2023	n/a	n/a	-HK$35m
Sep 30 2023	n/a	n/a	-HK$29m
Jun 30 2023	n/a	n/a	-HK$36m
Mar 31 2023	HK$1m	HK$1m	-HK$42m
Dec 31 2022	n/a	n/a	-HK$38m
Sep 30 2022	n/a	n/a	-HK$35m
Jun 30 2022	n/a	n/a	-HK$23m
Mar 31 2022	HK$2m	HK$1m	-HK$12m
Dec 31 2021	n/a	n/a	-HK$11m
Sep 30 2021	n/a	n/a	-HK$9m
Jun 30 2021	n/a	n/a	-HK$8m
Mar 31 2021	HK$2m	HK$1m	-HK$8m
Dec 31 2020	n/a	n/a	-HK$23m
Sep 30 2020	n/a	n/a	-HK$38m
Jun 30 2020	n/a	n/a	-HK$37m
Mar 31 2020	HK$2m	HK$1m	-HK$37m
Dec 31 2019	n/a	n/a	-HK$29m
Sep 30 2019	n/a	n/a	-HK$22m
Jun 30 2019	n/a	n/a	-HK$22m
Mar 31 2019	HK$2m	HK$2m	-HK$23m
Dec 31 2018	n/a	n/a	-HK$24m
Sep 30 2018	n/a	n/a	-HK$25m
Jun 30 2018	n/a	n/a	-HK$32m
Mar 31 2018	HK$2m	HK$2m	-HK$39m

Compensatie versus markt: De totale vergoeding ($USD 156.67K ) Ho } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 233.84K ).

Compensatie versus inkomsten: De vergoeding van Ho is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Ho Chung (61 yo)

6.8yrs

Tenure

HK$1,218,000

Compensatie

Mr. Ho Chung has been an Executive Director at China Health Group Limited since December 28, 2012 and has been its Chief Executive Officer since December 11, 2017. Mr. Chung has an experience in investment...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Fan Zhang	Executive Chairman	7.8yrs	HK$1.22m	27.93% HK$ 103.0m
Ho Chung	CEO & Executive Director	6.8yrs	HK$1.22m	geen gegevens
Yong Xing	Executive Director	less than a year	HK$300.00k	0.028% HK$ 104.9k
Jiuru Ding	Chief Financial Officer	6.6yrs	geen gegevens	geen gegevens
Amy Yu	Chief Operating Officer and Vice President	no data	geen gegevens	geen gegevens
Siu Hung Tsui	Company Secretary	15.6yrs	geen gegevens	geen gegevens
Peiyuan Qiu	Senior Consultant	5.1yrs	HK$130.00k	geen gegevens

6.6yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 673 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Fan Zhang	Executive Chairman	7.8yrs	HK$1.22m	27.93% HK$ 103.0m
Ho Chung	CEO & Executive Director	11.8yrs	HK$1.22m	geen gegevens
Yong Xing	Executive Director	3.1yrs	HK$300.00k	0.028% HK$ 104.9k
Jingming Wang	Non-Executive Director	10.4yrs	HK$100.00k	0.58% HK$ 2.1m
Xuejun Jiang	Independent Non-Executive Director	no data	HK$100.00k	geen gegevens
Lianhai Huang	Non-Executive Director	no data	HK$100.00k	geen gegevens
Yanhua Du	Independent Non-Executive Director	no data	HK$100.00k	geen gegevens
Liangquan Lai	Independent Non-Executive Director	no data	HK$100.00k	geen gegevens

9.1yrs

Gemiddelde duur

58.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 673 wordt beschouwd als ervaren (gemiddelde ambtstermijn 9.1 jaar).

China Health Group Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Here's Why China Health Group Limited's (HKG:673) CEO Compensation Is The Least Of Shareholders' Concerns

Non-Executive Director recently bought HK$291k worth of stock

China Health Group Limited Announces Redesignation of Xing Yong from A Non- Executive Director to an Executive Director

China Health Group Limited, Annual General Meeting, Sep 12, 2024

Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation

China Health Group Limited, Annual General Meeting, Sep 18, 2023

Recent updates

New minor risk - Share price stability

Here's Why China Health Group Limited's (HKG:673) CEO Compensation Is The Least Of Shareholders' Concerns

Non-Executive Director recently bought HK$291k worth of stock

China Health Group Limited Announces Redesignation of Xing Yong from A Non- Executive Director to an Executive Director

Full year 2024 earnings released: HK$0.085 loss per share (vs HK$0.099 loss in FY 2023)

China Health Group Limited, Annual General Meeting, Sep 12, 2024

New minor risk - Shareholder dilution

Full year 2024 earnings released: HK$0.084 loss per share (vs HK$0.099 loss in FY 2023)

China Health Group Limited to Report Fiscal Year 2024 Results on Jun 27, 2024

First half 2024 earnings released: HK$0.032 loss per share (vs HK$0.066 loss in 1H 2023)

New major risk - Revenue and earnings growth

China Health Group Limited to Report First Half, 2024 Results on Nov 30, 2023

Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation

New minor risk - Shareholder dilution

China Health Group Limited, Annual General Meeting, Sep 18, 2023

Full year 2023 earnings released: HK$0.099 loss per share (vs HK$0.03 loss in FY 2022)

New minor risk - Insider selling

Full year 2023 earnings released: HK$0.099 loss per share (vs HK$0.03 loss in FY 2022)

China Health Group Limited to Report Fiscal Year 2023 Results on Jun 30, 2023

Executive Chairman recently bought HK$932k worth of stock

First half 2023 earnings released: HK$0.066 loss per share (vs HK$0.013 loss in 1H 2022)

We Think China Health Group (HKG:673) Has A Fair Chunk Of Debt

First half 2023 earnings released: HK$0.066 loss per share (vs HK$0.013 loss in 1H 2022)

China Health Group Limited Provides Earning Guidance for the Six Months Ended 30 September 2022

China Health Group Limited to Report First Half, 2023 Results on Nov 30, 2022

Less than half of directors are independent

We Discuss Why China Health Group Limited's (HKG:673) CEO May Deserve A Higher Pay Packet

China Health Group Limited, Annual General Meeting, Sep 30, 2022

Full year 2022 earnings released: HK$0.003 loss per share (vs HK$0.002 loss in FY 2021)

Full year 2022 earnings released

China Health Group Limited to Report Fiscal Year 2022 Results on Jun 30, 2022

China Health Group Limited announced that it expects to receive HKD 82 million in funding

Less than half of directors are independent

First half 2022 earnings: Revenues and EPS in line with analyst expectations

First half 2022 earnings: Revenues and EPS in line with analyst expectations

We Think Some Shareholders May Hesitate To Increase China Health Group Limited's (HKG:673) CEO Compensation

Full year 2021 earnings released: HK$0.002 loss per share (vs HK$0.009 loss in FY 2020)

No-Executive Director has left the company

China Health Group Limited Announces Board Changes

Did China Health Group Limited (HKG:673) Insiders Sell Shares?

First half 2021 earnings released: HK$0.001 loss per share

First half 2021 earnings released: HK$0.001 loss per share

China Health Group Limited to Report First Half, 2021 Results on Nov 30, 2020

Full year earnings released - HK$0.0089 loss per share

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd